HomeCancer

Cancer

Asciminib monotherapy in sufferers with chronic-phase power myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up outcomes

Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, et al. European LeukemiaNet 2020 suggestions for treating power myeloid leukemia....

Groundbreaking examine uncovers hundreds of cancer-causing genetic variants

(Credit score: CI Photographs/Shutterstock) HINXTON, United Kingdom — In a landmark discovery, scientists have recognized over 5,000 genetic variants that allow sure cancers to...

Predictors of intention to obtain cervical most cancers screening amongst business intercourse employees in Gondar metropolis, northwest Ethiopia: software of the idea of deliberate...

Kumar V, Abbas AK, Aster JC. Robbins fundamental pathology e-book. Elsevier Well being Sciences; 2017.Ferlay J, Ervik J, Lam F, Colombet M, Mery...

Hot Topics